IGM Biosciences, Inc.
Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof

Abstract:

This disclosure provides dimeric, pentameric, and hexameric Tumor Necrosis Factor (TNF) superfamily receptor protein binding molecules and methods of using such binding molecules to direct apoptosis-mediated killing of TNF receptor-expressing cells.